top of page
Architects of Liver Regeneration
How can we boost liver function in patients?
Addressing a worldwide epidemic:
-
Chronic liver disease affects 100 Million people worldwide with NO current treatment other than liver transplantation ​
-
​No solution exists other than organ transplantation, which only treats a fraction of patients​
-
Cirrhosis is debilitating and affects relatively younger patients in their most productive years​​​
-
New technologies and solutions are needed to boost liver function in terminally ill patients
Innovation-Driven Solutions
Khufu Therapeutics is a pre-seed stage biotechnology company employing novel bioengineering technologies to tackle liver disease.
-
A vicious cycle of increasing cirrhosis, increasing mortality, and lack of treatments is escalating liver disease worldwide
-
Khufu Therapeutics is developing liver bioengineering platforms that permanently restore liver mass, architecture, and function, in patients with liver disease.
Khufu's founders have over 20 years of research and experience in medicine and surgery, bioengineering, tissue engineering, stem cells, regenerative engineering, synthetic biology, bioinformatics, bioreactors, and GMP manufacturing.
bottom of page